Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

Delayed Data
As of Oct 12
 -0.26 / -2.69%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Stemline Therapeutics Inc have a median target of 38.00, with a high estimate of 50.00 and a low estimate of 30.00. The median estimate represents a +303.40% increase from the last price of 9.42.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Stemline Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.41%
Growthannually 0.72%


Growthquarterly -23.91%
Growthannually 29.50%
Key to the earnings and sales forecast charts.